Clinical Trials Browser

INDUSTRY × Radiotherapy, Intensity-Modulated × Clear all

NCT07219212 2026-04-13

LUMIRAY

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT02937272 2026-04-03

A Study of LY3200882 in Participants With Solid Tumors

Phase 1 Active not recruiting

Camurati-Engelmann Syndrome

NCT04373785 2025-10-21

NG101m Adjuvant Therapy in Glioblastoma Patients

Phase 1/2 Not yet recruiting

Glioblastoma

NCT06056310 2025-09-29

Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

Phase 1 Terminated

18 enrolled 9 charts

Head and Neck Neoplasms, Laryngeal Diseases

NCT05966194 2024-11-15

KEVLARx

Phase 2 Recruiting

Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT04895345 2024-09-26

A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03840902 2024-01-16

M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

Phase 2 Terminated

153 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung

NCT06011291 2023-10-27

A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer

Phase 1 Unknown

Head and Neck Neoplasms

NCT04529850 2022-08-16

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Phase 2 Completed

38 enrolled 10 charts

Head and Neck Neoplasms, Stomatitis

NCT02508389 2021-09-20

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Phase 2 Completed

223 enrolled 17 charts

Squamous Cell Carcinoma of Head and Neck, Stomatitis

NCT02805894 2021-05-10

NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma

Phase 1/2 Terminated

Prostatic Neoplasms

NCT02555644 2019-02-15

A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer

Phase 1 Completed

Head and Neck Neoplasms, Neoplasms

NCT01266512 2014-07-16

C-CRISP

Phase 2 Completed

Lung Neoplasms